Lijuan Ma

585 citations
49 papers · 384 indexed · h-index 12
Topics
Streptococcal Infections and Treatments (5 papers)Respiratory viral infections research (5 papers)Pneumonia and Respiratory Infections (5 papers)
Partner nations
ChinaUnited StatesYemen

In The Last Decade

Lijuan Ma

45 papers receiving 380 citations

Peers

Lijuan Ma
Comparison fields: 5 of 85
  • Epidemiology 138
  • Molecular Biology 69
  • Pulmonary and Respiratory Medicine 61
  • Infectious Diseases 48
  • Surgery 47
Replace Xiaoling Zou with:
Xiaoling Zou China
Kaili Deng China
Richard H. West Australia
Tom Deutschle Germany
Tidi Hassan Ireland
Yueping Zeng China
Jason M. Long United States
Işın Y. Comba United States
Jianchao Ying China
William Alexander Japan
Lijuan Ma relative to Xiaoling Zou China Xiaoling Zou's profile →
Citations per field
00.5×1.5×
Xiaoling Zou · 1×
Citations per year

Countries citing papers authored by Lijuan Ma

Since Specialization
Citations

This map shows the geographic impact of Lijuan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lijuan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lijuan Ma more than expected).

Fields of papers citing papers by Lijuan Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lijuan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lijuan Ma. The network helps show where Lijuan Ma may publish in the future.

Co-authorship network of co-authors of Lijuan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Lijuan Ma. A scholar is included among the top collaborators of Lijuan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lijuan Ma. Lijuan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 5
3 0
4 3
5 7
6 11
7 2
8 1
9 1
10 12
11 4
12 45
13 5
14 11
15 8
16 15
17 9
18 2
19 2
20
Effects of Drug Serum of Valeriana jatamansi on the Splenic Lymphocytes and Peritoneal Macrophages in Mice
1

About Lijuan Ma

Lijuan Ma is a scholar working on Microbiology, Clinical Biochemistry and Infectious Diseases, having authored 49 papers that have together received 384 indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (5 papers), Respiratory viral infections research (5 papers) and Pneumonia and Respiratory Infections (5 papers). The work is most often cited by research in Microbiology (37 citations), Epidemiology (138 citations) and Pollution (39 citations). Lijuan Ma has collaborated with scholars based in China, United States and Yemen. Frequent co-authors include Yifeng Lu, Junjun Chang, Lin Zhou, Seon-Ju Kim, Kwon Ik Oh, Yuan Cheng, Yu Li, Yingying Pei, Dongqing Hou and Guanhua Xue. Their work appears in journals such as PLoS ONE, Diabetes and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026